the Liver Transplant Hospital affiliated with Turgut Özal Medical Center of İnönü University of Malatya/Turkey.
Malatya, Turkey (Türkiye)
Completed
NCT Number: NCT05995938
Mindfullnes-Based Cognitive Therapy Effect
Objective: In this study, the effect of mindfulness-based cognitive therapy on compliance with immunosuppressive therapy in liver transplant patients was evaluated. Method: It was conducted the study in a randomized controlled type with n=120 participation of liver transplant recipients of a transplant hospital. It was applied mindfulness-based cognitive therapy to liver recipients in the experimental group.
Completed
Looking for future studies?
Notify MeKey information
Age range
18 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
About this study
It was used simple random sampling method in assigning liver recipients to the experimental and control groups. Discharged liver transplant patients are informed about the use of immunosuppressive drugs and the drug is prescribed. Liver transplant patients drugs.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Inclusion Criteria involved (i) being a liver transplant recipient, (ii) currently having immunosuppressive treatment, (iii) being 18 years or older (iv) having no language or communication barrier and (v) agreeing to participate in the study.
Liver transplant recipients
Exclusion criteria
- The exact opposite of the inclusion criteria the exclusion criteria.
Treatment and study plan
Mindfullnes-Based Cognitive Therapy
BehavioralMindfullnes-Based Cognitive Therapy Effect on Adherence to Immunosuppressive Therapy in Liver Transplant Recipients
Other names: [Mindfulness]
Primary outcomes
-
The Effect of Mindfulness-Based Cognitive after Liver Transplantation
Time frame: Both groups experiment and control. It was used Mindfullnes scale and immunosuppressive terapy adherence scale. It was done measure before and after Mindfullnes-Based Cognitive Therapy.
It will be measure Therapy on Liver Transplant Recipients' Adherence to Immunosuppressive Therapy
Secondary outcomes
-
Mindfullnes-Based Cognitive Therapy
Time frame: total of six month.from 1 october 2022 to 30 Jan 2023
le level of Mindfulness-Based Cognitive
Sponsors and collaborators
Lead sponsor
SEMRA BÜLBÜLOĞLU
Other
Registry information
Official study title
Mindfullnes-Based in Surgery Patients for Cognitive Therapy Effect
Acronym: [Mindfullnes]
Important dates
- Study start
- 2022
- Primary completion
- 2023
- Study completion
- 2023
- First posted
- Aug 16, 2023
- Registry last updated
- Aug 16, 2023
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.